EndoQuest Robotics has officially launched its pivotal PARADIGM clinical trial with the successful completion of its first two robotic endoscopic submucosal dissection (ESD) procedures. Performed by renowned colorectal surgeon Dr. Eric Haas, the trial is testing EndoQuest’s groundbreaking Endoluminal Surgical (ELS) System—a flexible, single-use robotic platform designed for scar-free, natural orifice surgery.
If proven effective, the system could transform how complex colorectal lesions are treated, making minimally invasive options more accessible. But as the U.S. remains slow to adopt ESD due to technical challenges, the real question looms: can robotics finally tip the scale?